Becton, dickinson and company:1106636 [16-013221] - OEM service contract for influx cell sorter.

Ended Purchase Order Awarded Last action

Contract number
HHSN261201600114P
Awardee
Awarding agency
Obligated
$39,028

Award facts

Opportunity
Contract value 20% obligated
  • $39,028.48 Current, with exercised options
  • $195,142.56 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Competed under SAP · 2 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 · DE-obligation of funds from FY2016 expiring lines. -$0
Original award $39,029

About this award

The National Cancer Institute issued a purchase order to Becton, Dickinson and Company for OEM service contract support for an Influx cell sorter, valued at $195,142.56, awarded April 1, 2016.

Place of performance is Bethesda, Maryland. The order carried a firm fixed price and no small business set-aside. Ultimate completion was scheduled for April 28, 2021. The purchase order represented a de-obligation of funds from FY2016 expiring lines.

Quick answers

Who was awarded contract HHSN261201600114P?

HHSN261201600114P was awarded to Becton, Dickinson And Company by National Cancer Institute (National Institutes of Health) on April 1, 2016.

How much is contract HHSN261201600114P worth?

The government has obligated $39,028 on HHSN261201600114P. Its potential value, with all options, is $195,143.

Was contract HHSN261201600114P competed?

The extent of competition for HHSN261201600114P was competed under sap. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award